Shingles, ko kuma herpes zoster, wani kamuwa da cuta ne wanda cutar ta haifar da ita kamar pox . Rashin gaggawa mai yawan gaske shine mafi yawan al'ada yayin da mutum ya tsufa, kuma an yi imani cewa wannan zai iya zama saboda rashin karfin yanayi da shekaru na aikin rigakafi. Duk da haka, akwai wani wuri wanda aka gano shingles a cikin mutanen da ke cikin shekaru daban-daban - wato daga cikin tsarin rashin ƙarfi.
Saboda haka da ciwon ciwon sankarar jini ko lymphoma, da / ko ana bi da su saboda shi, zai sanya ka cikin haɗari da yawa na bunkasa wannan kamuwa da cuta.
Bayani
Idan kuna da pox kaza a baya, ko kuma idan an yi masa alurar riga kafi , cutar bata taba barin tsarinka ba. Magunguna na kwakwalwan ƙwayoyin cuta suna dauke da wata nakasawar cutar, wadda ke da damar haifar da shingles daga baya a rayuwa. Ko da daɗewa bayan rashin lafiyar kajin kajin ya tafi, kwayar cutar tana cikin wani yanayi mai dorewa ko hutawa a cikin jikin kwayoyin jikinsu. Harsoyin cutar sun ɓace, kuma kwayar cutar ta kiyaye shi ta hanyar tsarin lafiya. A wasu lokuta, ana iya sake cutar cutar kamar shingles.
Wane ne yake da hadari?
Idan ba a taba samun kaji ba ko kuma an yi masa maganin alurar riga kafi, zaka iya kashe ƙugiya, amma yana da wuyar ganewa cewa mutum bai taba cutar da cutar ba bisa ga tarihi, kadai.
Haɗarin shingles masu tasowa ya fi girma a cikin tsofaffi. A gaskiya ma, za'a iya sake saurin cutar ta sau biyu kowace shekara 10 a kan shekaru 50.
Mutanen da ke fama da matsalar rigakafin da aka raunana suna cikin babban haɗari don bunkasa shingles. Lokacin da tsarinka na rigakafi ya ba da damar kiyaye shi, cutar ta dauki damar da za ta sake aiki.
Idan kana da jini ko ciwon daji, irin su lymphoma ko cutar sankarar bargo, akwai wasu dalilai da dama da ke sanya ka cikin hadari don rage yawan rigakafi:
- Ciwon daji na kanka
- Chemotherapy
- Rashin farfasawa zuwa wani yanki na jikinka tare da babban nau'in ɓarna mai tausayi , irin su ƙashin ƙugu
- Jirgin steroid
- Sashin murmushi ko ƙaddara sashi
Babban mahimmancin haɗari ga abin da ke faruwa na maganin cututtukan hoto kamar shingles shine ƙimar abin da aka sani da rigakafin kwayoyin halitta. Rashin haɗari yana ƙaruwa tare da kawar da kwayoyin T, jigilar ƙarancin sojojin soja na jikinka, kamar yadda aka gani a cikin kwayar cutar ta kwayar cuta a lokacin magani tare da T-cell antibody alemtuzumab. Neutropenia - ko ƙananan ƙwayoyin jini masu tsarran kwayar neutrophil - na iya kara haɗarin sauran cututtuka, amma neutropenia, shi kaɗai, ya nuna ba shi da muhimmanci a yanayin shingles.
Dangane da likitan ciwon daji da aka ba, tasirin shingles zai iya bambanta. Alal misali, nazarin APEX ya nuna yawan karuwar shingles a marasa lafiya da ke karɓar bortezomib, don haka za'a iya yin shawarwari don amfani da ƙananan abu acyclovir ko valacyclovir.
Cutar cututtuka
Kwayar shingles mai aiki ta biyo bayan jijiyar inda ya kasance dormant. Mafi sau da yawa, yana nuna kanta a cikin wani rukuni a gefe ɗaya na jiki.
Shingles yana da yawa a kan tayin amma zai iya faruwa a ko'ina, ciki har da fuska da tsauraran ku.
Na farko alama ce da za ku iya fuskanta shi ne zafi, ƙwaƙwalwa, ƙona ko tingling tare da jijiya da fata kewaye da shi. A wasu lokuta, wannan alama ce kawai alama ce da kake da ita.
Yawancin mutane za su ci gaba da raguwa a cikin kwanaki 1-5 masu zuwa. Fatar jiki a kan jijiyar da ke fama da shi zai yi kama da ja da ƙura, kuma za a sami mummunan rauni, mai raɗaɗi mai raɗaɗi - kamar pox na kaza. Kowace damuwa zai zauna na kusan mako guda zuwa kwanaki 10 kafin bushewa sama da juya launin rawaya.
Hakanan zaka iya shawo kan cututtuka (zazzabi, gajiya, ciwon kai) yayin da kake da gaggawa.
Shin Shingles ne?
Har sai raunin shingles ya bushe, yana yiwuwa a gare ka ka aika da kaji zuwa ga wanda bai taba samun shi ba ko kuma wanda ba a yi masa rigakafi ba. Mutane masu lafiya waɗanda suka riga sun sami pox maraba ba su da wata babbar haɗari na kamuwa da cutar. Amma, lallai ya kamata ku guji kasancewar hulɗa da wasu waɗanda suka rasa ƙarfi, da tsofaffi da ƙananan yara, waɗanda ba su taɓa samun macijin kaza ba, da masu juna biyu.
Sanin asali
Yawancin likitoci na iya gano shingles kawai ta hanyar kallon raguwa da jin labarinku. A wasu lokuta, mutanen da suka raunana rigakafi na iya samun samfurori na rarraba ga ƙyama, kuma likitan ku iya zaɓar aika swab don gwaji don tabbatar.
Jiyya
Manufar shingles magani shi ne ya gaggauta warke da kuma ci gaba da haƙuri dadi. Yin amfani da magungunan magunguna - irin su acyclovir, famciclovir, da valacyclovir - ba za su kashe kwayar cutar ba, amma zasu taimaka wajen rage tsawon lokaci har sai raguwa zai warke da rage yawan ciwo.
Ana yawan ba da maganin maganin maganin rigakafin maganin rigakafi, amma magungunan magunguna na iya zama dole a cikin lokuta masu tsanani ko a yanayi na musamman. Domin ya zama mafi mahimmanci, dole ne a fara yaduwar cutar antiviral cikin sa'o'i 72 na farko wanda alamun sun kasance.
Gudanar da ciwo yana da mahimmanci a kula da shingles. Magungunan magunguna, irin su acetaminophen da ibuprofen, sun fi dacewa don magance cututtukan shingles , amma a wasu yanayi mai tsanani, magunguna, antidepressants, da kuma magunguna masu amfani da kwayoyi zasu iya amfani da su wajen inganta ciwon ciwo .
Saboda kana da tsarin raunin da ya raunana, har ila yau kana cikin haɗarin tasowa daga kamuwa da ƙwayar cuta a kan fata. Wannan zai iya zama mafi maimaita idan kun kasance a cikin raguwa. Yana da mahimmanci a gare ku ku kiyaye yankin ya tsabta. Mai sanyaya, damun rufi na iya taimakawa, kuma za'a iya amfani dashi a ko'ina cikin yini na minti 20 a lokaci daya.
Matsaloli
Yawancin lokaci, fashewa na shingles yana da 'yan makonni kuma abubuwan da ke faruwa sune iyakancewa. Duk da haka, yana yiwuwa don inganta ƙarin matsalolin. Wasu daga cikinsu sun haɗa da:
- Scars a kan fata
- Ƙananan cututtuka daga magungunan bude
- Ramsay Hunt ciwo , wanda ya hada da hangen nesa da asarar ji
- Cutar da aka watsa , wanda cutar ta shafar fiye da ɗaya gefen jiki. A wannan misali, rash da bayyanar cututtuka zasu kasance mai tsanani kuma zai iya haifar da ciwon huhu ko hanta da ƙwaƙwalwar kwakwalwa
- Zuciyar zane , wanda kwayoyin ido ke ciki. Wannan zai haifar da makanta
- Bayanin ƙwaƙwalwar ƙwayar cuta , wanda kwayoyin jijiyoyi suka lalace ta hanyar cutar. Wannan zai sa mai haƙuri ya ci gaba da ciwo, ko da bayan sauran alamun kamuwa da cuta sun wuce
Idan ka yi tunanin za ka iya samun shingles, tuntuɓi mai bada sabis na kiwon lafiya a wuri-wuri. Yin farawa a kan dacewa da kyau a lokaci mai kyau zai rage haɗarin damuwa na tsawon lokaci daga shingles.
Takaitaccen
Cutar da jini da cututtukan jini kamar cutar sankarar jini ko lymphoma, da kuma maganin su, na iya haifar da wata hanyar da ta raunana, wasu sassan da aka danganta da haɗarin haɗari don bunkasa shingles.
Zai yiwu shingles su haifar da rikitarwa na tsawon lokaci. Ana iya rage yiwuwar waɗannan rikice-rikicen lokacin da aka fara farfado a cikin farkon 72 hours na bayyanar cututtuka. Kasancewa game da alamun gargaɗin shingles da kuma tuntuɓar cibiyar kula da lafiyar ku a nan gaba zai iya taimakawa wajen sauƙin kamuwa da ku.
> Sources:
> Kelvin, J., Tyson, L. (2005). Tambayoyi da Amsoshin Game da Ciwo da cututtukan cututtuka da ciwon ƙwayar cuta. Jones da Bartlett: Sudbury, MA.
> Marrs, J. Rash: Shin Shingles ne? Labarin Clinical Journal of Oncology Nursing Agusta, 2006. 10: 463-464.
> Sandy, M. Herpes Zoster: Gudanarwa da Nursing Management. Jaridar Clinical Journal of Incology Nursing Agusta 2005. 9: 443- 445.
> Sandherr M, Hentrich M, von Lilienfeld-Toal M, et al. Antiviral Prophylaxis a cikin marasa lafiya da tumatir masu ƙarfi da halayen malignancies - Update of Guidelines of the Disease Diseases Working Group (AGIHO) na Jamhuriyar Jamus don Ilimin Halittu da Kwayoyin Kimiyya (DGHO). Ann Hematol. 2015; 94 (9): 1441-50.
> Chanan-Khan A, Sonneveld P, Schuster MW, et al. Bincike na Harkokin Harkokin Harkokin Harkokin Harkokin Harkokin Harkokin Harkokin Herpes Daga cikin Bortezomib-Treated Patients a cikin binciken na APEX na Phase III. J Jara Incol . 2008; 26: 4784-4790.
> Ainihi OA, Ullmann AJ, Karthaus M. Abun Hanyoyin Hanyoyin Cutar Bayan Bayan Jiyya tare da Monoclonal Antibodies. Wien Med Wochenschr. 2004; 154: 209-217.